712 related articles for article (PubMed ID: 9892211)
1. Epidermal growth factor (EGF) receptor blockade inhibits the action of EGF, insulin-like growth factor I, and a protein kinase A activator on the mitogen-activated protein kinase pathway in prostate cancer cell lines.
Putz T; Culig Z; Eder IE; Nessler-Menardi C; Bartsch G; Grunicke H; Uberall F; Klocker H
Cancer Res; 1999 Jan; 59(1):227-33. PubMed ID: 9892211
[TBL] [Abstract][Full Text] [Related]
2. Asbestos causes stimulation of the extracellular signal-regulated kinase 1 mitogen-activated protein kinase cascade after phosphorylation of the epidermal growth factor receptor.
Zanella CL; Posada J; Tritton TR; Mossman BT
Cancer Res; 1996 Dec; 56(23):5334-8. PubMed ID: 8968079
[TBL] [Abstract][Full Text] [Related]
3. Essential role for G proteins in prostate cancer cell growth and signaling.
Kue PF; Daaka Y
J Urol; 2000 Dec; 164(6):2162-7. PubMed ID: 11061948
[TBL] [Abstract][Full Text] [Related]
4. Elevation of cyclic adenosine 3',5'-monophosphate potentiates activation of mitogen-activated protein kinase by growth factors in LNCaP prostate cancer cells.
Chen T; Cho RW; Stork PJ; Weber MJ
Cancer Res; 1999 Jan; 59(1):213-8. PubMed ID: 9892209
[TBL] [Abstract][Full Text] [Related]
5. Epidermal growth factor induces insulin receptor substrate-2 in breast cancer cells via c-Jun NH(2)-terminal kinase/activator protein-1 signaling to regulate cell migration.
Cui X; Kim HJ; Kuiatse I; Kim H; Brown PH; Lee AV
Cancer Res; 2006 May; 66(10):5304-13. PubMed ID: 16707456
[TBL] [Abstract][Full Text] [Related]
6. The phosphatidylinositol 3'-kinase pathway is a dominant growth factor-activated cell survival pathway in LNCaP human prostate carcinoma cells.
Lin J; Adam RM; Santiestevan E; Freeman MR
Cancer Res; 1999 Jun; 59(12):2891-7. PubMed ID: 10383151
[TBL] [Abstract][Full Text] [Related]
7. Sirt1 inhibitor, Sirtinol, induces senescence-like growth arrest with attenuated Ras-MAPK signaling in human cancer cells.
Ota H; Tokunaga E; Chang K; Hikasa M; Iijima K; Eto M; Kozaki K; Akishita M; Ouchi Y; Kaneki M
Oncogene; 2006 Jan; 25(2):176-85. PubMed ID: 16170353
[TBL] [Abstract][Full Text] [Related]
8. Changes in androgen receptor nongenotropic signaling correlate with transition of LNCaP cells to androgen independence.
Unni E; Sun S; Nan B; McPhaul MJ; Cheskis B; Mancini MA; Marcelli M
Cancer Res; 2004 Oct; 64(19):7156-68. PubMed ID: 15466214
[TBL] [Abstract][Full Text] [Related]
9. Activation and glucagon regulation of mitogen-activated protein kinases (MAPK) by insulin and epidermal growth factor in cultured rat and human hepatocytes.
Ulrich RG; Cramer CT; Adams LA; Kletzien RF
Cell Biochem Funct; 1998 Jun; 16(2):77-85. PubMed ID: 9636995
[TBL] [Abstract][Full Text] [Related]
10. A cross-talk between the androgen receptor and the epidermal growth factor receptor leads to p38MAPK-dependent activation of mTOR and cyclinD1 expression in prostate and lung cancer cells.
Recchia AG; Musti AM; Lanzino M; Panno ML; Turano E; Zumpano R; Belfiore A; Andò S; Maggiolini M
Int J Biochem Cell Biol; 2009 Mar; 41(3):603-14. PubMed ID: 18692155
[TBL] [Abstract][Full Text] [Related]
11. Multiple mitogenic pathways in pancreatic cancer cells are blocked by a truncated epidermal growth factor receptor.
Matsuda K; Idezawa T; You XJ; Kothari NH; Fan H; Korc M
Cancer Res; 2002 Oct; 62(19):5611-7. PubMed ID: 12359775
[TBL] [Abstract][Full Text] [Related]
12. Prolactin modulates phosphorylation, signaling and trafficking of epidermal growth factor receptor in human T47D breast cancer cells.
Huang Y; Li X; Jiang J; Frank SJ
Oncogene; 2006 Dec; 25(58):7565-76. PubMed ID: 16785991
[TBL] [Abstract][Full Text] [Related]
13. Androgen receptor activation in prostatic tumor cell lines by insulin-like growth factor-I, keratinocyte growth factor, and epidermal growth factor.
Culig Z; Hobisch A; Cronauer MV; Radmayr C; Trapman J; Hittmair A; Bartsch G; Klocker H
Cancer Res; 1994 Oct; 54(20):5474-8. PubMed ID: 7522959
[TBL] [Abstract][Full Text] [Related]
14. [Studies on cell signaling immunomodulated murine peritoneal suppressor macrophages: LPS and PMA mediate the activation of RAF-1, MAPK p44 and MAPK p42 and p38 MAPK].
Chang ZL; Lin MQ; Wang MZ; Yao Z
Shi Yan Sheng Wu Xue Bao; 1997 Mar; 30(1):73-81. PubMed ID: 10684111
[TBL] [Abstract][Full Text] [Related]
15. The RIalpha subunit of protein kinase A (PKA) binds to Grb2 and allows PKA interaction with the activated EGF-receptor.
Tortora G; Damiano V; Bianco C; Baldassarre G; Bianco AR; Lanfrancone L; Pelicci PG; Ciardiello F
Oncogene; 1997 Feb; 14(8):923-8. PubMed ID: 9050991
[TBL] [Abstract][Full Text] [Related]
16. Response to transforming growth factor alpha (TGFalpha) and epidermal growth factor (EGF) in hepatocytes: lower EGF receptor affinity of TGFalpha is associated with more sustained activation of p42/p44 mitogen-activated protein kinase and greater efficacy in stimulation of DNA synthesis.
Thoresen GH; Guren TK; Sandnes D; Peak M; Agius L; Christoffersen T
J Cell Physiol; 1998 Apr; 175(1):10-8. PubMed ID: 9491776
[TBL] [Abstract][Full Text] [Related]
17. Vasoactive intestinal peptide transactivates the androgen receptor through a protein kinase A-dependent extracellular signal-regulated kinase pathway in prostate cancer LNCaP cells.
Xie Y; Wolff DW; Lin MF; Tu Y
Mol Pharmacol; 2007 Jul; 72(1):73-85. PubMed ID: 17430995
[TBL] [Abstract][Full Text] [Related]
18. Multiple responses to EGF receptor activation and their abrogation by a specific EGF receptor tyrosine kinase inhibitor.
Harper ME; Goddard L; Glynne-Jones E; Assender J; Dutkowski CM; Barrow D; Dewhurst OL; Wakeling AE; Nicholson RI
Prostate; 2002 Jun; 52(1):59-68. PubMed ID: 11992620
[TBL] [Abstract][Full Text] [Related]
19. IGF-I and vasoactive intestinal peptide (VIP) regulate cAMP-response element-binding protein (CREB)-dependent transcription via the mitogen-activated protein kinase (MAPK) pathway in pituitary cells: requirement of Rap1.
Fernández M; Sánchez-Franco F; Palacios N; Sánchez I; Cacicedo L
J Mol Endocrinol; 2005 Jun; 34(3):699-712. PubMed ID: 15956341
[TBL] [Abstract][Full Text] [Related]
20. Protein kinase A-Ialpha subunit-directed antisense inhibition of ovarian cancer cell growth: crosstalk with tyrosine kinase signaling pathway.
Alper O; Hacker NF; Cho-Chung YS
Oncogene; 1999 Sep; 18(35):4999-5004. PubMed ID: 10490835
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]